At the snd of the day no one is selling because were at .50 cents. More of a question of will this attract the 13-d and all the anti nadars to buy back in knowing that buyout becomes more of reality since mew CEO won’t be looking to get triple digits. I still think based on other buyouts drugs that have had much much much less potential and much more downside safety wise going in range of 30 billion.